-
2023-504989-37-00
5
Metastatic Squamous Non-small Cell Lung Cancer
-
2025-520554-11-00
5
Cardiovascular Disease
-
2025-522791-92-00
5
Neoplasm Metastasis
-
2025-523461-17-01
5
LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
-
2025-523522-41-00
10
Extensive-Stage Small Cell Lung Cancer
-
2025-523526-40-00
9
Advanced Solid Tumors
-
2025-523586-18-00
5
Non-Small Cell Lung Cancer
-
2025-524103-69-00
10
Chronic Venous Insufficiency
-
2025-523269-31-00
3
2026-06-02
Hormone receptor-positive early breast cancer in post-menopausal women
-
2025-524498-17-00
10
2026-05-08
Pretreated Unresectable Locally Advanced or Metastatic human epidermal
-
2025-521314-25-00
5
2026-03-19
NPM1-m and KMT2A-r Acute Myeloid Leukemia
-
2023-505661-89-00
4
2025-12-19
Early-stage, Hormone Receptor (HR)-positive / Human Epidermal Growth F
-
2025-520979-13-00
5
2025-12-18
Patients with HR+ HER2- early breast cancer at intermediate risk of re
-
2024-516792-32-01
4
2025-07-18
Metastatic non-squamous non-small cell lung cancer
-
2024-512360-55-00
4
2025-06-30
Unresectable locally recurrent or metastatic hormone receptor (HR)-pos
-
2023-507097-41-01
5
2025-03-20
Patients with limited-stage small cell lung cancer (LS-SCLC)
without
-
2024-512484-31-00
4
2025-02-28
FGFR2b-positive, advanced or metastatic adenocarcinoma of the stomach
-
2024-512926-27-00
5
2024-12-12
patients with estrogen receptor-positive/human epidermal growth factor
-
2023-508441-41-00
6
2024-07-08
Bacteriemia producida por P. aeruginosa.
-
2023-510275-64-00
9
2023-05-31
Hepatocellular carcinoma, colorectal cancer, endometrial
cancer, or ot
-
2022-501007-28-00
5
2023-04-18
Breast Neoplasms
-
2023-509335-60-00
1
2023-02-23
Advanced solid tumors including (but not limited to), non-small cell l
-
2023-505749-14-00
5
2022-03-20
c-Met overexpressing EGFR wildtype non-squamous non-small cell lung ca
-
2023-509628-16-00
5
2026-05-07
Small Cell Lung Cancer (SCLC)